However, the therapy at this dosage also led to a high incidence of side effects such as joint pain (50% of patients) and swelling in the limbs (37% of patients) [13]
Dulaglutide modulates the development of tissue-infiltrating T H 1/T H 17 cells and the pathogenicity of encephalitogenic T H 1 cells in the central nervous system
Gastrointestinal effects represent the most frequently reported adverse reactions, occurring in a substantial proportion of patients, particularly during treatment initiation and dose escalation: Nausea (very common, affecting more than 1 in 10 people) typically peaks during the first few weeks and often diminishes with continued treatment [1] [2] Diarrhoea (very common, affecting more than 1 in 10 people) Vomiting (common, affecting up to 1 in 10 people) Abdominal pain, constipation, and dyspepsia occur with variable frequency Reduced appetite is an expected pharmacological effect contributing to weight loss but may occasionally be excessive These gastrointestinal symptoms usually improve over time as the body adjusts to the medication
In September, the active ingredients of these drugs not the brand names were added to the WHOs Essential Medicines List which guides national health systems in making medicine procurement decisions
Peptidic GLP-1 receptor agonists such as semaglutide or the triple-agonist substance retatrutide function mechanistically through the same receptor family but are built as amino acid chains
)
:max_bytes(150000):strip_icc():focal(749x0:751x2)/Oprah-Winfrey-weight-loss-123025-f855bdf931834a91b603253b473a6370.jpg)
